Author Archives: Lillian

Featured Stories
Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Transvaginal Mesh a Nightmare for Thousands of Women

Transvaginal Mesh a Nightmare for Thousands of Women

Thousands of women who have received transvaginal mesh surgical implants to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are now living a nightmare, thanks to debilitating pain, bleeding, infection and other serious complications. According to the Sun-Sentinel, many of the women injured by transvaginal mesh claim ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Lawsuits Claiming NuvaRing Causes Blood Clots Continue to Build

NuvaRing is being linked to a series of thrombotic issues leading to serious health problems and litigation. The birth contol device can allegedly cause blood clots, some of which can be fatal. Manufacturers such as Merck & Co. are being … Continue reading

Posted in NuvaRing, Pharmaceuticals |

Health Concerns and Litigation over Yaz/Yasmin Birth Control

Bayer is being widely criticized over Yaz and Yasmin, two similar types of oral contraceptives. The popular birth control pills are reportedly responsible for causing blood-clots, with some instances resulting in death. In light of the evidence, advisors to the … Continue reading

Posted in Pharmaceuticals, Yaz / Yasmin |

Actos Linked to Bladder Cancer

Takeda’s Actos, the diabetes drug, has been linked to possible cases of bladder cancer. After studies established a connection between the drug and disease, the widely used medication was taken off the shelves in two European countries last June. Shortly … Continue reading

Posted in Actos, Pharmaceuticals |

Prior to Hip Implant Recall, DePuy Discussed FDA Concerns

Over the past few years, DePuy Orthopaedics has experienced several setbacks concerning their artificial hip implants. The company, which is a subsidiary of Johnson & Johnson, had recalled two of their products in September 2010 due to a high rate … Continue reading

Posted in Defective Medical Devices, Depuy, Metal Hip Implants |

Depakote Legal Troubles Not Over for Abbott

Depakote continues to pose more legal challenges for Abbott Laboratories (ABT). Among other issues, the company has allegedly violated consumer protection laws in relation to Depakote’s sale and marketing. After allegations of off-market labeling and U.S. Justice Department investigation last … Continue reading

Posted in Depakote, Pharmaceuticals |

Medtronic Spine Sales Still Steadily Dropping in Wake of Infuse Controversies

Medtronic, Inc., sales have continued to decline after months of skepticism surrounding some of their products and practices. The company is experiencing a particularly bad quarter with regards to implantable heart defibrillators and spine products, which are two of their … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

MS Drug Gilenya Under Review in Europe, but Still Deemed Safe by FDA

US medical professionals are continuing to back Novartis’ Gilenya (fingolimod) despite the growing concern following several cases of patient death in the past few months. To investigate the effects of Gilenya on one’s cardiovascular health, the European Medicines Agency (EMA) … Continue reading

Posted in Gilenya, Pharmaceuticals |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.